Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 5, Number 3—June 1999


Hepatitis C Virus RNA Viremia in Central Africa

On This Page

Article Metrics



Views: Views equals page views plus PDF downloads

Metric Details

Cite This Article


Highlight and copy the desired format.

EID Cancré N, Grésenguet G, Mbopi-Kéou F, Kozemaka A, Mohamed AS, Matta M, et al. Hepatitis C Virus RNA Viremia in Central Africa. Emerg Infect Dis. 1999;5(3):484-486.
AMA Cancré N, Grésenguet G, Mbopi-Kéou F, et al. Hepatitis C Virus RNA Viremia in Central Africa. Emerging Infectious Diseases. 1999;5(3):484-486. doi:10.3201/eid0503.990330.
APA Cancré, N., Grésenguet, G., Mbopi-Kéou, F., Kozemaka, A., Mohamed, A. S., Matta, M....Bélec, L. (1999). Hepatitis C Virus RNA Viremia in Central Africa. Emerging Infectious Diseases, 5(3), 484-486.

To the Editor: Epidemiologic serosurveys have demonstrated high prevalence (6%-15%) of hepatitis C virus (HCV) infection in adults in sub-Saharan Africa (1-4). Although possible false-positive HCV serologic test results have been reported in Africa, HCV prevalence rates suggest a high rate of chronic infection among persons with anti-HCV antibodies (5,6). We have focused on HCV RNA infectivity of blood from donors attending the National Blood Center in Bangui, Central African Republic.

We prospectively tested all blood donors between February and April 1998 for serum anti-HCV antibodies by both an HCV third-generation enzyme-linked immunosorbent assay (ELISA) (Abbott HCV EIA 3.0 test, Abbott, Chicago, IL, USA), which was chosen as a reference test for immunoglobulin (Ig) G antibodies to HCV, and by a simple membrane immunoassay system (Ortho HCV Ab Quik Pack, Ortho Diagnostic Systems Inc., Tokyo, Japan) (7). Anti-HCV-positive serum samples were further subjected to qualitative detection of HCV RNA by reverse transcription-polymerase chain reaction (AMPLICOR-HCV, Roche Diagnostic Systems, Inc., Branchburg, NJ, USA) (8). Of 163 serum samples (mean age ± standard deviation, 30±8 years), 155 were from male blood donors, 83 (51%) from first-time donors, and 125 (77%) from donors in the recipient's family. Fifteen (9.2%; 95% confidence interval [CI] 5%-15%) samples contained IgG to HCV by ELISA. Of the ELISA-positive samples, 14 were positive by the Quik Pack assay (sensitivity, 93.0%); of the 148 remaining ELISA-negative samples, 147 were negative by the Quik Pack assay (specificity, 99.3%). The agreement between the results of the two methods was 98.7%. Of the 163 samples, 10 (6.1%; CI 95%: 3%-11%) were positive for HCV antibodies (by ELISA and rapid test) and for HCV RNA.

We confirmed a high prevalence of HCV-seropositivity among blood donors in Bangui and the subsequent high rate of HCV RNA viremic blood donations. To offset the major risk for transfusion-acquired HCV in Central Africa we recommend screening donated blood for anti-HCV. When laboratory facilities to perform ELISA are not available, the Quik Pack system, a simple reliable method for detecting anti-HCV antibodies in human serum that requires neither complex reagent preparation nor expensive instrumentation, could prove useful.


Nicole Cancré*, Gérard Grésenguet†, François-Xavier Mbopi-Kéou‡, Alain Kozemaka†, Ali Si Mohamed*, Mathieu Matta*, Jean-Jacques Fournel§, and Laurent Bélec*

Author affiliations: *Université Pierre et Marie Curie, Hôpital Broussais, Paris, France; †Centre National de Transfusion Sanguine, Bangui, République Centrafricaine; ‡London School of Hygiene and Tropical Medicine, London, United-Kingdom; and; §Hôpital de la Pitié-Salpêtrière, Paris, France



  1. Ndumbe PM, Skalsky J. Hepatitis C virus infection in different populations in Cameroon. Scand J Infect Dis. 1993;25:68992. DOIPubMed
  2. Xu LZ, Larzul D, Delaporte E, Bréchot C, Kremsdorf D. Hepatitis C virus genotype 4 highly prevalent in Central Africa (Gabon). J Gen Virol. 1994;75:23938. DOIPubMed
  3. Fretz C, Jeannel D, Stuyver L, Herve V, Lunel F, Boudifa A, HCV Infection in a rural population of Central African Republic (CAR): evidence for three additional subtypes of genotype 4. J Med Virol. 1995;47:4357. DOIPubMed
  4. Pawlotsky JM, Bélec L, Grésenguet G, Desforges L, Bouvier M, Duval J, High prevalence of hepatitis B, C and E markers in young sexually active adults from the Central African Republic. J Med Virol. 1995;46:26973. DOIPubMed
  5. Aceti A, Taliani D. Hepatitis C virus testing in African sera. Ann Intern Med. 1992;116:427.PubMed
  6. Callahan JD, Constantine NT, Kataaha P, Zhang X, Hyams KC, Bansal J. Second generation hepatitis C virus assays: performance when testing African sera. J Med Virol. 1993;41:358. DOIPubMed
  7. Kodama T, Ichiyama S, Sato K, Nada T, Nakashima N. Evaluation of a membrane filter assay system, Ortho HCV Ab Quik Pack, for detection of anti-hepatitis C virus antibody. J Clin Microbiol. 1998;36:143940.PubMed
  8. Young KKY. R. Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol. 1993;31:8826.PubMed


Cite This Article

DOI: 10.3201/eid0503.990330

Related Links


Table of Contents – Volume 5, Number 3—June 1999